High Expression Levels of X-Linked Inhibitor of Apoptosis Protein and Survivin Correlate with Poor Overall Survival in Childhood de Novo Acute Myeloid Leukemia

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-03-0642PMID 15173080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in the expression pattern of apoptosis-related molecules between childhood and adult de novo acute myeloid leukemia.

  2004cited by this paper
• Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).

  2003cited by this paper
• Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-XLand XIAP in the prolonged survival of monocytic cells

  2003cited by this paper
• Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.

  2003cited by this paper
• Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia

  2003cited by this paper
• Assessment of caspase activity as a possible prognostic factor in acute myeloid leukaemia

  2002cited by this paper
• Cytogenetics in acute myeloid leukemia

  2002cited by this paper
• Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group.

  2002cited by this paper
• Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.

  2002cited by this paper
• Activation of the MEK/MAPK pathway is involved in bryostatin1-induced monocytic differenciation and up-regulation of X-linked inhibitor of apoptosis protein.

  2002cited by this paper
• Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients

  2001cited by this paper
• Cytokine-regulated expression of survivin in myeloid leukemia.

  2001cited by this paper
• Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view.

  2001cited by this paper
• Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

  2001influential reference
• Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93

  2001cited by this paper
• Apoptosis: implications of basic research for clinical oncology.

  2001cited by this paper
• Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia.

  2000cited by this paper
• Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

  2000cited by this paper
• Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.

  2000influential reference
• Expression and prognostic significance of survivin in de novo acute myeloid leukaemia

  2000cited by this paper
• Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.

  2000cited by this paper
• Molecular genetics, natural history and the demise of childhood leukaemia.

  1999cited by this paper
• Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics

  1999influential reference
• Management of acute myeloid leukemia in elderly patients.

  1999cited by this paper
• Anti-apoptosis gene, survivin, and prognosis of neuroblastoma.

  1998cited by this paper
• Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas.

  1998cited by this paper
• Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia.

  1998cited by this paper
• IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

  1998cited by this paper
• High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate

  1997cited by this paper
• A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

  1997cited by this paper
• Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: possible correlation with sensitivity to chemotherapy.

  1997influential reference
• Biology of acute leukaemia.

  1997cited by this paper
• Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.

  1995cited by this paper
• Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

  1995cited by this paper
• Proposals for the immunological classification of acute leukemias.

  1995cited by this paper
• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

  1985cited by this paper
• An international system for human cytogenetic nomenclature

  1978cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper

• Mechanisms of programmed cell death: structural and functional pathways. A narrative review.

  2024cites this paper
• Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold.

  2023cites this paper
• Targeted Degradation of XIAP is Sufficient and Specific to Induce Apoptosis in MYCN-overexpressing High-risk Neuroblastoma

  2023cites this paper
• Recent developments in photodynamic therapy and its application against multidrug resistant cancers

  2023cites this paper
• Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance

  2023cites this paper
• The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of Harakiri and downregulation of XIAP in vitro.

  2022cites this paper
• A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer

  2022cites this paper
• A phase I study of LCL161, a novel oral pan‐inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumors

  2022cites this paper
• Advances in immunotherapeutic targets for childhood cancers: a focus on glypican-2 and B7-H3.

  2021cites this paper
• Discovery of N-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor.

  2021cites this paper
• Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer

  2020cites this paper
• Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer

  2020cites this paper
• TCR-based Immunotherapy for Hematologic Malignancies

  2019cites this paper
• Predicting E3 Ubiquitin Ligases as Possible Promising Biomarkers for Brain Tumors

  2019cites this paper
• Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia

  2019cites this paper
• Inhibition of p53 inhibitors: progress, challenges and perspectives

  2019cites this paper
• The XIAP inhibitor embelin sensitises malignant rhabdoid tumour cells to TRAIL treatment via enhanced activation of the extrinsic apoptotic pathway.

  2019cites this paper
• T-Cell Receptor–Based Immunotherapy for Hematologic Malignancies

  2019cites this paper
• Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism

  2019cites this paper
• Ugi efficient synthesis, biological evaluation and molecular docking of coumarin-quinoline hybrids as apoptotic agents through mitochondria-related pathways.

  2019cites this paper
• The multi-factorial nature of clinical multidrug resistance in cancer.

  2019influential citation
• Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia

  2019cites this paper
• Destined to Die: Apoptosis and Pediatric Cancers

  2019cites this paper
• Clinicopathological and functional implications of the inhibitor of apoptosis proteins survivin and XIAP in esophageal cancer.

  2018cites this paper
• Cell Death: Mechanisms and Pathways in Cancer Cells

  2018cites this paper
• Knockdown of SRPX2 inhibits the proliferation, migration, and invasion of prostate cancer cells through the PI3K/Akt/mTOR signaling pathway

  2018cites this paper
• Evaluation of tissue metalloproteinase inhibitor TIMP-1 and Survivin levels during third trimester pregnancy - a preliminary report.

  2017cites this paper
• Protein network related to unfavorable prognosis in Acute Myeloid Leukemia

  2017cites this paper
• Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells

  2017cites this paper
• Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia.

  2017cites this paper
• Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins

  2017cites this paper
• Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)

  2017cites this paper
• Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia

  2017cites this paper
• Inhibitors of apoptosis: clinical implications in cancer

  2017cites this paper
• Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells

  2017cites this paper
• Targeting apoptosis in acute myeloid leukaemia

  2017cites this paper
• Evaluation of the cytotoxic, apoptosis inducing activity and molecular docking of spiroquinazolinone benzamide derivatives in MCF-7 breast cancer cells.

  2016cites this paper
• Calcineurin and GSK-3 inhibition sensitizes T-cell acute lymphoblastic leukemia cells to apoptosis through X-linked inhibitor of apoptosis protein degradation

  2016cites this paper
• APOPTOSIS: MECANISMOS CELULARES

  2016cites this paper
• Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer Treatment.

  2016cites this paper
• Surviving Ratio as a Parameter for Chemotherapy Induction Response in Children with Acute Myeloid Leukemia

  2016cites this paper
• The expression pattern of APC2 and APC7 in various cancer cell lines and AML patients.

  2015cites this paper
• Prognostic value of inhibitor of apoptosis protein family expression in patients with acute myeloid leukemia

  2015cites this paper
• Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias

  2015cites this paper
• The Proapoptotic F-box Protein Fbxl7 Regulates Mitochondrial Function by Mediating the Ubiquitylation and Proteasomal Degradation of Survivin*

  2015cites this paper
• XIAP and Ki-67: A Correlation Between Antiapoptotic and Proliferative Marker Expression in Benign and Malignant Tumours of Salivary Gland: An Immunohistochemical Study.

  2015cites this paper
• Survivin Hakkinda Bilinenler: Survivin ile İlgili Türkiye'de Yapilmiş Olan Çalişmalar

  2015cites this paper
• Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemia.

  2015cites this paper
• Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport.

  2015cites this paper
• Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP.

  2015cites this paper
• Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival

  2015cites this paper
• Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein

  2015cites this paper
• Survivin Hakkında Bilinenler: Survivin ile İlgili Türkiye’de Yapılmış Olan Çalışmalar

  2015cites this paper
• Title: Targeting Survivin with YM155 (sepantronium bromide): A novel therapeutic strategy for paediatric acute myeloid leukemia

  2014cites this paper
• X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary

  2014cites this paper
• Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death

  2014cites this paper
• Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities

  2014cites this paper
• BIRC 5 ( Survivin ) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia : A Report From the Children ’ s Oncology Group

  2014cites this paper
• XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells

  2014cites this paper
• X-Linked Inhibitor of Apoptosis Protein – A Critical Death Resistance Regulator and Therapeutic Target for Personalized Cancer Therapy

  2014cites this paper
• Confers Immunity Against Intracel lular Bacteria

  2014cites this paper
• Targeting the apoptosis pathway in hematologic malignancies

  2014cites this paper
• BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: A report from the Children's Oncology Group

  2014cites this paper
• Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors.

  2014cites this paper
• Monitoring Survivin Expression in Cancer: Implications for Prognosis and Therapy

  2013cites this paper
• Defective Apoptosis Signaling in Cancer

  2013cites this paper
• Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions

  2013cites this paper
• Phase I Trial of AEG35156 an Antisense Oligonucleotide to XIAP Plus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

  2013cites this paper
• Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3.

  2013cites this paper
• Inhibitor of Apoptosis Proteins in Pediatric Leukemia: Molecular Pathways and Novel Approaches to Therapy

  2013cites this paper
• Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.

  2013cites this paper
• Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia

  2013cites this paper
• Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines?

  2013cites this paper
• Cell Death Signaling in Cancer Biology and Treatment

  2013cites this paper
• XIAP antisense therapy with AEG 35156 in acute myeloid leukemia

  2013cites this paper
• The Expression of Caspase-3 and Survivin Related with Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia

  2013cites this paper
• cells and predicts poor clinical outcomes in AML leukemic stem/progenitor - 38 + Survivin is highly expressed in CD34

  2013cites this paper
• X-Linked IAP

  2013cites this paper
• Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML.

  2012cites this paper
• Endogenous anticancer mechanisms (EACMs).

  2012cites this paper
• Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells

  2012cites this paper
• Endogenous knockdown of survivin improves chemotherapeutic response in ALL models

  2012cites this paper
• Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies

  2012cites this paper
• Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling

  2012cites this paper
• Biochemical investigation of anti-cancer activity of Tulbaghia violacea

  2012cites this paper
• p53/Surviving Ratio as a Parameter for Chemotherapy Induction Response in Children with Acute Myeloid Leukemia

  2012cites this paper
• Differentiation and Cell Survival of Myeloid Leukemia Cells

  2012cites this paper
• Targeting IAP proteins for therapeutic intervention in cancer

  2012cites this paper
• Smac mimetic LBW242 sensitizes XIAP-overexpressing neuroblastoma cells for TNF-α-independent apoptosis.

  2012cites this paper
• Referenzen des Kompetenznetzes „Akute und chronische Leukämien“

  2012cites this paper
• Survivin is highly expressed in CD34 (cid:1) 38 (cid:2) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML

  2012cites this paper
• The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia

  2012cites this paper
• Cutting-Edge Apoptosis-Based Therapeutics

  2012cites this paper
• Noscapine Induced Apoptosis via Downregulation of Survivin in Human Neuroblastoma Cells Having Wild Type or Null p53

  2012cites this paper
• Study of survivin and X-linked inhibitor of apoptosis protein (XIAP) genes in acute myeloid leukemia (AML).

  2012cites this paper
• Role of exosomes released by Chronic Myelogenous Leukemia in the modulation of tumor microenvironment

  2012cites this paper
• Effect of interaction of magnetic nanoparticles of Fe3O4 and artesunate on apoptosis of K562 cells

  2011cites this paper
• Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.

  2011cites this paper
• Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study.

  2011cites this paper
• Targeting IAPs as an approach to anti-cancer therapy.

  2011cites this paper